Health Canada
- Status: approved
🇨🇦 subcutaneous tocilizumab in Canada
subcutaneous tocilizumab (subcutaneous tocilizumab) regulatory status in Canada.
Marketing authorisation
subcutaneous tocilizumab in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is subcutaneous tocilizumab approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for subcutaneous tocilizumab in Canada?
Centre Hospitalier Régional d'Orléans is the originator. The local marketing authorisation holder may differ — check the official source linked above.